CVS Health Corp NewsLatest News On CVS Health Corp Jim Cramer says CVS stock is a buy at these levels. Here's why8/25/2025 7:37 PM Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors8/24/2025 6:46 AM Here are Monday's biggest analyst calls: Nvidia, Apple, Tesla, Duolingo, Netflix, Target, CVS, Sunrun, Live Nation & more8/18/2025 10:42 AM UBS upgrades CVS to buy rating, sees further recovery ahead8/18/2025 10:30 AM Here are Thursday's biggest analyst calls: Nvidia, Amazon, AMD, Cisco, CoreWeave, Sunrun & more8/14/2025 7:14 AM Eli Lilly earnings are coming Thursday. Here's what top analysts expect8/6/2025 5:49 PM High-quality, low-volatility stocks to consider if market turmoil upends the next two months8/4/2025 8:46 PM Trump administration announces new private health tracking system with Big Tech’s help7/31/2025 8:32 PM Why Jim Cramer backs Meta's AI spending — and the latest on Apple and Amazon ahead of earnings7/31/2025 12:34 PM Stocks making the biggest moves midday: Generac, Shake Shack, Microsoft, Meta & more7/31/2025 12:33 PM CVS Health hikes 2025 forecast again, boosted by insurance, pharmacy businesses7/31/2025 11:27 AM The Fed stays on hold, and the key numbers to watch when Meta and Microsoft report7/30/2025 7:35 PM Morgan Stanley's highest conviction picks into earnings7/23/2025 1:50 PM Obesity drug prices are dropping, but getting a steady supply remains a challenge7/6/2025 11:19 PM Guard against market volatility in the second half with ‘boring’ stocks, investor Jeff Kilburg says7/3/2025 6:27 AM Stocks making the biggest moves midday: Tesla, Centene, Robinhood, Nike and more7/2/2025 10:51 AM Major U.S. health insurers say they will streamline controversial process for approving care6/23/2025 3:47 AM Louisiana AG investigating CVS for sending mass text messages lobbying against legislation6/12/2025 7:42 PM The market has finally left overbought territory — and why Cramer is watching health-care stocks5/22/2025 2:57 PM We’re adding to our position in this out-of-favor, high-quality drugmaker stock5/22/2025 10:47 AM